DSP Healthcare Fund Direct-Growth

One of the largest AMCs in India, DSP has been helping investors make sound investment decisions responsibly and unemotionally for over 25 years.

DSP is backed by the DSP Group, an almost 160-year-old Indian financial giant. The family behind DSP has been very influential in the growth and professionalization of capital markets and the money management business in India over the last one-and-a-half centuries.

About DSP Healthcare Fund Direct-Growth

Investment objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity-related securities of pharmaceutical and healthcare companies. 

Investment process  

This thematic fund invests in established & upcoming companies in the pharmaceutical & healthcare space in India and internationally (primarily, in the United States).

While selecting stocks, they focus on their growth, value, and stability. In portfolio construction, they maintain a judicious balance between sub-segments and maintain liquidity considered for stock sizing. 

Portfolio composition 

The portfolio major exposure of 40% in large cap followed by 23% in small cap. The top 3 sectors hold nearly 94% of the portfolio, with major exposure to Pharmaceuticals and Biotechnology.

portfolio-composition
Note: Data as of 30th Nov 2022. The bar graph shows the top 5 sector weightage of the fund’s portfolio. 
Source: dspim.com 

Top 5 holdings

Name Sector Weightage % 
Sun Pharmaceuticals Industries Ltd. Pharmaceutical 16.48 
Cipla Ltd. Pharmaceutical 9.33 
Apollo Hospitals Enterprise Ltd. Healthcare Company 6.96 
IPCA Laboratories Ltd. Pharmaceutical 5.42 
Lupin Ltd. Pharmaceutical 5.41 
Note: Data as of 30th Nov 2022. 
Source: ICICI Pru

DSP Healthcare Fund Direct-Growth: performance over 4 years 

If you would have invested 10,000 at the inception of the DSP Healthcare Fund, it would be now valued at Rs. 22,427. This fund has outperformed the benchmark in all time horizons.

performance-4-years DSP Healthcare Fund Direct-Growth
Note: Performance of the fund since launch. Inception date – Nov 30th, 2018. 
Source: Moneycontrol 

The DSP Healthcare Fund has given consistent returns and has outperformed the benchmark over the period of more than 4 years by generating a CAGR (Compounded Annual Growth Rate) of 22.01% 

Fund Managers 

  • Chirag Dagli: Chirag has a total work experience of Over 20 years. He joined DSP Investment Managers in November 2020 as Vice President in Equity Team. He is a Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree. 
  • Vinit Sambre: Total work experience of 16 years. Vinit joined DSPIM in July 2007, as Portfolio Analyst for the firm’s Portfolio Management Services (PMS) division, which manages discretionary accounts and provides advisory services to institutional clients. 
  • Jay Kothari: Total work experience of 20 years. Vice President & Product Strategist -Jay has been with DSP Investment Managers since May 2005. He completed his Bachelor of Management Studies (Finance & International Finance) from Mumbai University, followed by an MBA in Finance from Mumbai University. 

Who should invest? 

  • An experienced investor with a well-defined core portfolio. 
  • Investors with high patience understand that sectoral bets may come with changing cycles. 

Why invest? 

  • Offers the potential to grow your wealth & ‘earn big’ returns if this theme does well (a high-risk, high-return strategy). 
  • Can help you beat the impact of rising prices over the long term. 

Horizon 

  • One should look at investing and holding the investment for more than 7 years. 
  • Investment through a Systematic Investment Plan (SIP) may help in tackling the volatility of the broader equity market. 

FAQs

Who should invest in DSP Healthcare Fund? 
  • An experienced investor with a well-defined core portfolio. 
  • Investors with high patience understand that sectoral bets may come with changing cycles. 
What has DSP Healthcare Fund Direct-Growth performance been like over 4 years? 

If you would have invested 10,000 at the inception of the DSP Healthcare Fund, it would be now valued at Rs. 22,427. This fund has outperformed the benchmark in all time horizons. The DSP Healthcare Fund has given consistent returns and has outperformed the benchmark over the period of more than 4 years by generating a CAGR (Compounded Annual Growth Rate) of 22.01% 

What is DSP Healthcare Fund Direct-Growth’s investment approach?

This thematic fund invests in established & upcoming companies in the pharmaceutical & healthcare space in India and internationally (primarily, in the United States).

While selecting stocks, they focus on their growth, value, and stability. In portfolio construction, they maintain a judicious balance between sub-segments and maintain liquidity considered for stock sizing. 

Conclusion 

This DSP Healthcare Fund offers favourable sector dynamics – Rising income levels, increasing health consciousness, and government policies mean an increase in healthcare spending, so companies in this space could do well.

This scheme is suitable for an investor with a high-risk appetite and who believes in high-risk high rewards. 

Consult an expert advisor to get the right plan